Flinton Capital Management LLC decreased its position in Neogen Co. (NASDAQ:NEOG) by 17.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 12,384 shares of the company’s stock after selling 2,560 shares during the period. Flinton Capital Management LLC’s holdings in Neogen were worth $856,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of NEOG. First Trust Advisors LP raised its holdings in shares of Neogen by 78.2% during the 1st quarter. First Trust Advisors LP now owns 14,884 shares of the company’s stock valued at $976,000 after purchasing an additional 6,530 shares in the last quarter. UBS Asset Management Americas Inc. raised its holdings in shares of Neogen by 19.0% during the 1st quarter. UBS Asset Management Americas Inc. now owns 20,838 shares of the company’s stock valued at $1,366,000 after purchasing an additional 3,330 shares in the last quarter. Karp Capital Management Corp bought a new position in shares of Neogen during the 1st quarter valued at $1,032,000. Sei Investments Co. raised its holdings in shares of Neogen by 4.5% during the 1st quarter. Sei Investments Co. now owns 6,378 shares of the company’s stock valued at $418,000 after purchasing an additional 275 shares in the last quarter. Finally, Mason Street Advisors LLC raised its holdings in shares of Neogen by 7.8% during the 1st quarter. Mason Street Advisors LLC now owns 8,879 shares of the company’s stock valued at $582,000 after purchasing an additional 639 shares in the last quarter. 86.12% of the stock is owned by institutional investors.
Several research analysts have recently issued reports on the stock. BidaskClub lowered shares of Neogen from a “buy” rating to a “hold” rating in a research report on Friday, August 18th. Zacks Investment Research lowered shares of Neogen from a “buy” rating to a “hold” rating in a research report on Friday. Finally, CL King initiated coverage on shares of Neogen in a research report on Friday, July 14th. They set a “neutral” rating on the stock.
Neogen Co. (NASDAQ:NEOG) traded up 0.21% during trading on Tuesday, reaching $77.57. 2,995 shares of the company’s stock were exchanged. Neogen Co. has a 52-week low of $50.53 and a 52-week high of $79.99. The firm has a market cap of $2.97 billion, a P/E ratio of 65.18 and a beta of 1.51. The stock’s 50 day moving average price is $73.61 and its 200 day moving average price is $67.06.
Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Tuesday, September 19th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.01. The company had revenue of $95.30 million during the quarter, compared to analyst estimates of $94.87 million. Neogen had a return on equity of 9.97% and a net margin of 12.53%. The firm’s revenue was up 14.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 earnings per share. Equities research analysts anticipate that Neogen Co. will post $1.32 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Neogen Co. (NASDAQ:NEOG) Shares Sold by Flinton Capital Management LLC” was first reported by BBNS and is the sole property of of BBNS. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://baseballnewssource.com/markets/flinton-capital-management-llc-has-856000-position-in-neogen-corporation-neog/1698914.html.
In other news, VP Edward Bradley sold 5,000 shares of the firm’s stock in a transaction on Wednesday, July 19th. The stock was sold at an average price of $66.33, for a total transaction of $331,650.00. Following the completion of the transaction, the vice president now directly owns 86,512 shares in the company, valued at $5,738,340.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider James L. Herbert sold 14,513 shares of the firm’s stock in a transaction on Wednesday, October 4th. The shares were sold at an average price of $78.32, for a total value of $1,136,658.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 158,543 shares of company stock valued at $11,750,418. 4.20% of the stock is owned by corporate insiders.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Co. and related companies with our FREE daily email newsletter.